Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyumjev vs Humalog in Adults with T1D Using Insulin Pumps
NCT03830281Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2019
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Feb 2019; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03830281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830281.